Anavex Life Sciences Corp (AVXL)

[Gator328]

The fact the stock price is selling for a 10% premium to the offering price indicates the market has confidence in SAVA.

I don't know that Anavex will have the same sort of confidence factor for a while, even if it does report positive top-line data on 12/1. Partly because SAVA is more well known and partly because SAVA hasn't attracted the ire of pseudo-journalists like Adam Feuerstein, who is allowed to request an advance copy of the abstract (makes it easy to pre-write articles and have them published minutes after the data embargo is lifted).

Is it possible that Dr. Missling is selling shares? We'll know in a few months. More likely though is that it's a combination of tax loss selling and the final chance to lock in profits or mitigate risk before CTAD.